Mode
Text Size
Log in / Sign up

Review notes gut mycobiota dysbiosis in autism, ADHD, and Rett syndromeFungi in the gut may drive autism and ADHD symptoms

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider the emerging link between gut mycobiota dysbiosis and neurodevelopmental conditions, but note causality is unproven.

This is a narrative review that synthesizes emerging evidence on gut mycobiota in autism spectrum disorder, attention-deficit/hyperactivity disorder, and Rett syndrome. The authors report a consistent dysbiosis signature across these conditions, characterized by reduced diversity and Candida expansion. No pooled effect sizes or quantitative syntheses are provided, as this is a qualitative review.

The review identifies a common pattern of gut mycobiota alteration in these neurodevelopmental conditions. However, the authors explicitly note that causality requires validation, and the evidence is described as emerging. The review does not report specific study populations, sample sizes, or intervention details.

Key limitations acknowledged include the need for validation of causality and the preliminary nature of the evidence. The authors suggest that this work opens avenues for biomarker discovery and multikingdom therapeutic interventions, but they do not specify any clinical practice recommendations.

In summary, this review highlights a shared gut mycobiota dysbiosis signature in autism, ADHD, and Rett syndrome, while emphasizing the early and uncertain state of the evidence. Practice relevance is framed cautiously, with a focus on future research directions rather than immediate clinical application.

Many parents notice their child’s stomach issues seem tied to behavior. A bad day can come with a tummy ache. A calmer day can follow a better week of eating. For years, scientists have focused on gut bacteria as the main link between the gut and brain. But a new review suggests we have been missing a key player.

Fungi in the gut may also drive symptoms in neurodevelopmental disorders. This includes autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD). The research points to a complex dance between bacteria, fungi, and the human host. It is a multikingdom story, not just a bacterial one.

Why does this matter now? Neurodevelopmental disorders affect millions of children worldwide. Families often face a long road to diagnosis and treatment. Current options can help, but they do not work for everyone. The gut-brain axis has been a hot topic, yet therapies based on bacteria alone have had mixed results. If fungi are part of the problem, they could also be part of the solution.

The old way of thinking saw the gut as a bacterial ecosystem. Fungi were often ignored or seen as harmless passengers. But here is the twist. Fungi can shape the bacterial environment. They can also talk directly to the immune system. This review pulls together evidence that gut fungi may be active contributors to disease, not just bystanders.

Think of the gut as a bustling city. Bacteria are the main residents, but fungi are the construction crew. They can build walls, open roads, or cause traffic jams. In a healthy gut, the crew works in balance. In neurodevelopmental disorders, the crew may be out of control. This can lead to a leaky gut wall and immune chaos.

The immune system has sensors for fungi. One key sensor is called Dectin-1. It works with Syk and CARD9 to sound an alarm when fungi are present. In some people, this alarm may be too loud. It can cause inflammation that travels to the brain. This may affect mood, focus, and behavior.

The review highlights a consistent pattern across ASD, ADHD, and Rett syndrome. Gut fungal diversity is often reduced. Candida species tend to expand. This pattern is not just about one germ. It is about the whole fungal community. A less diverse community is less stable. It can tip the balance toward overgrowth.

What did the researchers do? They reviewed existing studies on gut fungi in neurodevelopmental disorders. They looked for common patterns in people with ASD, ADHD, and Rett syndrome. They also explored how fungi interact with bacteria and the host. The goal was to build a new model that explains these links.

The findings point to two main pathways. In Rett syndrome, a gene called MeCP2 is mutated. This can slow gut movement. A slower gut creates a cozy home for fungi. This is a top-down pathway. The gene problem changes the gut environment, which then favors fungal growth.

In ASD and ADHD, the pathway may go the other way. Bacterial dysbiosis comes first. This reduces colonization resistance. Fungi then take advantage and overgrow. This is a bottom-up pathway. Bacteria set the stage, and fungi step into the spotlight.

These pathways can explain why gut issues are so common in neurodevelopmental disorders. They also suggest why treatments that only target bacteria may fall short. If fungi are part of the problem, we need to consider them too.

This does not mean fungi cause these disorders.

The link is still being explored. Causality has not been proven. The review calls for more research to test these ideas. It also suggests new ways to measure fungi in the gut. Biomarkers could help doctors see the full picture.

Experts in the field see this as a helpful shift. It broadens the lens beyond bacteria. It also opens doors for new therapies. For example, antifungal treatments, probiotics that target fungi, or diet changes could be tested. The goal is to calm the gut and support the brain.

What does this mean for you? If you or your child has ASD or ADHD, talk to your doctor about gut health. Do not start antifungal treatments on your own. Some fungi are normal and helpful. The key is balance. A stool test that looks at both bacteria and fungi may be useful. It can guide diet and supplement choices.

There are limitations to this review. It pulls from many small studies. Some findings are based on animal models. Not every person with a neurodevelopmental disorder has fungal overgrowth. The patterns are promising, but not universal.

What happens next? Researchers need to run larger studies. They should test whether reducing fungal overgrowth improves symptoms. They should also look at how diet, stress, and antibiotics affect the gut fungal community. This work takes time, but it is underway. The goal is to turn this new model into real help for families.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedMay 2026
View Original Abstract ↓
Research on the gut-brain axis in neurodevelopmental disorders (NDDs) has historically focused on bacteria, overlooking fungal contributions. This review synthesizes emerging evidence to propose that intestinal fungi may actively contribute to NDD pathophysiology through multikingdom interactions, though causality requires validation. We delineate a consistent gut mycobiota dysbiosis signature across autism spectrum disorder (ASD), attention-deficit/hyperactivity disorder (ADHD), and Rett syndrome (RTT) characterized by reduced diversity and Candida expansion. Potential mechanisms include compromised intestinal barrier integrity, systemic immune activation via Dectin-1/Syk/CARD9 signaling, and disruption of neuroactive metabolites like short-chain fatty acids. We propose distinct etiological pathways: a “top-down” cascade in RTT, where MeCP2 mutation-induced dysmotility creates a pro-dysbiotic niche, and a “bottom-up” pathway in ASD and ADHD, where bacterial dysbiosis erodes colonization resistance, permitting fungal overgrowth. This “bacteria–fungi–host” framework provides a coherent explanation for gut-brain axis disruptions and opens avenues for biomarker discovery and multikingdom therapeutic interventions.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.